Acute Cellular Alterations in the Hippocampus After Status Epilepticus by Macdonald, Robert L. & Kapur, Jaideep
Epilepsia, 4O(Suppl. I):S9-S20, 1999 
Lippincott Williams i? Wilkins, Philadelphia 
0 International League Against Epilepsy 
Acute Cellular Alterations in the Hippocampus After 
Status Epilepticus 
Robert L. Macdonald and "Jaideep Kapur 
Department of Neurology, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. and *Department of Neurology, 
University of Virginia School of Medicine, Charlottesville, Virginia, USA.  
~~ 
Summary: The critical, fundamental mechanisms that deter- 
mine the emergence of status epilepticus from a single seizure 
and the prolonged duration of status epilepticus are uncertain. 
However, several general concepts of the pathophysiology of 
status epilepticus have emerged: (a) the hippocampus is con- 
sistently activated during status epilepticus; (b) loss of GABA- 
mediated inhibitory synaptic transmission in the hippocampus 
is critical for emergence of status epilepticus; and, finally (c) 
glutamatergic excitatory synaptic transmission is important in 
sustaining status epilepticus. This review focuses on the alter- 
ation of GABAergic inhibition in the hippocampus that occurs 
during the prolonged seizures of status epilepticus. If reduction 
in GABAergic inhibition leads to development of status epi- 
lepticus, enhancement of GABAergic inhibition would be ex- 
pected to interrupt status epilepticus. Benzodiazepines and bar- 
biturates are both used in the treatment of status epilepticus and 
both drugs enhance GABA, receptor-mediated inhibition. 
However, patients often become refractory to benzodiazepines 
when seizures are prolonged, and barbiturates are often then 
used for these refractory cases of status epilepticus. Recent 
evidence suggests the presence of multiple GABA, receptor 
isoforms in the hippocampus with different sensitivity to ben- 
zodiazepines but similar sensitivity to barbiturates, thus ex- 
~~~ ~ 
plaining why the two drug classes might have different clinical 
effects. In addition, rapid functional plasticity of GABA, re- 
ceptors has been demonstrated to occur during status epilepti- 
cus in rats. During status epilepticus, there was a substantial 
reduction of diazepam potency for termination of the seizures. 
The loss of sensitivity of the animals to diazepam during status 
epilepticus was accompanied by an alteration in the functional 
properties of hippocampal dentate granule cell GABA, recep- 
tors. Dentate granule cell GABA, receptor currents from rats 
undergoing status epilepticus had reduced sensitivity to diaze- 
pam and zinc but normal sensitivity to GABA and pentobar- 
bital. Therefore, the prolonged seizures of status epilepticus 
rapidly altered the functional properties of hippocampal dentate 
granule cell GABA, receptors, possibly explaining why ben- 
zodiazepines and barbiturates may not be equally effective dur- 
ing treatment of the prolonged seizures of status epilepticus. A 
comprehensive understanding of the cellular and molecular 
events leading to the development, maintenance, and cytotox- 
icity of status epilepticus should permit development of more 
effective treatment strategies and reduction in the mortality and 
morbidity of status epilepticus. Key Words: GABA- 
Hippocampus-Seizures-Status epilepticus. 
Most seizures are relatively brief and self-terminating. 
During some seizures, however, early termination fails 
and status epilepticus ensues. One hypothesis for devel- 
opment of status epilepticus is that activation of y-ami- 
nobutyric acid (GABA) receptor-mediated inhibition is 
responsible for normal termination of a seizure. If the 
GABAergic inhibition fails to terminate the seizure, a 
progressive reduction in GABA, receptor-mediated in- 
hibition develops which, when severe enough, results in 
a prolonged self-sustained seizure (1,2). There is experi- 
mental support for this hypothesis. Prolonged hippocam- 
pal seizures reduce GABA, receptor-mediated inhibi- 
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tion, and this reduction in inhibition can reliably predict 
occurrence of status epilepticus (3). Status epilepticus in 
humans also suggests a role for GABA, receptors be- 
cause it is treated with the benzodiazepines diazepam, 
lorazepam, and midazolam and the barbiturates pheno- 
barbital and pentobarbital, all of which exert their anti- 
convulsant effect by enhancing GABA, receptor- 
mediated inhibition (4). The GABA, receptor is the site 
of action of many of the antiepileptic drugs (AEDs) used 
to treat status epilepticus in humans, and there is direct 
evidence for altered properties of hippocampal GABA, 
receptors during status epilepticus. Therefore, it is im- 
portant to characterize the functional properties of 
GABA, receptors and the effect of status epilepticus on 
these properties to understand the pathogenesis and treat- 
ment of status epilepticus. 
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RECOMBINANT AND NATIVE 
GABA, RECEPTORS 
Properties and structure of recombinant 
GABA receptors 
GABA is the major inhibitory neurotransmitter in the 
CNS. It is released from GABAergic neurons and binds 
to several types of GABA receptors: GABA,, GABA,, 
and GABA, receptors. GABA, receptors mediate the 
majority of fast inhibition in the CNS. They are macro- 
molecular proteins that contain specific binding sites for 
GABA and for a number of allosteric regulators, includ- 
ing picrotoxin, barbiturates, benzodiazepines, and the an- 
esthetic steroids, and they form a chloride ion channel. 
On the basis of sequence similarity, six different 
GABA, receptor-subunit families have been identified 
and named: a-, p-, y-, 6-, E-, and rr-subunits. There is 
3 0 4 0 %  sequence identity among the subunit families. 
About 20-30% sequence homology exists among all 
GABA, receptor-subunit candidates and other gene 
products of the superfamily (5-7). Most of the subunit 
families have multiple members ((~1-6; pI-4; yl-4; and 
pl-2), and all of the sequences within each subunit fam- 
ily are homologous, with about 70-80% amino acid se- 
quence identity (Table 1). Additional diversity arises 
from RNA splice variants, described thus far for y2 (8) 
and p4 (9,lO). Each GABA, receptor-subunit cDNA en- 
codes for a polypeptide of about 50 kDa, with putative 
N-glycosylation sites and four a-helical, hydrophobic 
membrane-spanning regions (5,6). Between the third and 
fourth membrane-spanning regions is a putative hydro- 
philic cytoplasmic region of highly variable sequence 
involved in intracellular regulatory mechanisms such as 
phosphorylation. 
The current understanding of the molecular structure 
of the GABA,-receptor-ion channel complex is that it is 
a heteropentameric glycoprotein of about 275 kDa, com- 
posed of combinations of multiple polypeptide subunits. 
The subunits form a quasi-symmetric structure around 
the ion channel, with each subunit contributing to the 
wall of the channel (6). The model is based on the nico- 
tinic acetylcholine receptor, another member of the li- 
gand-gated ion channel gene superfamily, and electron 
microscopic image analysis of the native GABA, recep- 
tors (1 1). However, the number of each subtype and their 
stoichiometry remain uncertain. GABA, receptors are 
generally believed to be composed of combinations of 
a-, p-, y-, 6- and possibly €-subunits. The p-subunit 
forms homopentameric GABA, receptors in the retina; 
the role of the rr-subunit remains uncertain. 
TABLE 1. GABA, receptor subunit subtypes 
Subunits a B Y s  E 7r 
No. of subtypes 6 4 4 1 1  1 
No. of splice variants 0 4 1 0 Multiple 0 
Pharmacology of recombinant GABAA receptors 
The pharmacologic properties of GABA, receptors 
are dependent on subunit subtype composition. The ben- 
zodiazepine sensitivity of GABA, receptors differs 
when different a subtypes are combined with p- and 
y-subunits (Table 2) (12-16). The alpy-subunits pro- 
duce diazepam- and zolpidem-sensitive BZ 1 GABA, re- 
ceptors, a 2 p y -  and a3py-subunits produce BZ2a,b 
GABA, receptors with high diazepam and low zolpidem 
sensitivity, &Spy-subunits produce BZ2c GABA, recep- 
tors with high diazepam sensitivity but zolpidem insen- 
sitivity, and 014- or a6py-subunits produce BZ3 GABA, 
receptors that are benzodiazepine insensitive. Barbitu- 
rates bind to an allosteric regulatory site on the GABA, 
receptor, but the subunit location of the barbiturate bind- 
ing site is unknown. 
There is growing evidence for the structural diversity 
of native GABA, receptors derived from whole brain. 
The distribution of mRNAs in the CNS determined by in 
situ hybridization is very different for each subunit sub- 
type. For example, the p-subunit is expressed primarily 
in the retina (17), whereas various a, p, and y subtypes 
and the single 6 subtype show very different regional as 
well as developmental distributions ( 1  8-20). Immuno- 
precipitation studies have shown that different specific 
combinations of GABA, receptor-subtypes occur in the 
different regions of the brain. McKernan et al. (21) found 
that a majority of native GABAA receptors contain only 
a single a-subtype and that a l - ,  012-, a3-, or 1x5-subtypes 
exist in combination with a p- and a y2-subtype. Serum 
specific for the 6 subunit was found to precipitate a spe- 
cific set of GABA, receptors that contained a l ,  a3 
p2/3y2 subtypes but not the a5 subtype (22). Partial co- 
localization suggests some tentative major oligomeric as- 
semblies, e.g., Wisden et al. (19) propose the likely ex- 
istence of at least five combinations: (a) a lp2y2;  (b) 
a2p3yx; (c) a5p lyx ;  (d) ala4P26; and (e) aIa6p26. 
They also note that the yl-subunit is limited to the limbic 
regions of amygdala, hypothalamus, and septum. 
Hippocampal GABAA receptors 
It is likely that multiple specific GABA, receptor iso- 
forms are expressed in the hippocampus. The existence 
of GABA, receptor isoforms has been demonstrated by 
in vivo and in vitro pharmacologic studies. Immunopu- 
rification and in situ hybridization studies have shown 
that the subtypes display a heterogeneous distribution in 
the CNS. Experiments using subunit-specific antibodies 
for quantitative immunopurification of GABA, recep- 
tors from specific regions of the CNS and comparison of 
the identified subunit combinations with the localization 
of the corresponding mRNA have allowed initial identi- 
fication of the subunit composition of some GABA, 
receptor isoforms. Hippocampal dentate granule cells 
can potentially express GABA, receptors with distinct 
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TABLE 2. Subunit-spec f i c  pharmacologic properties of GABA, receptors 
Pharmacologic property Subunit subtypes 
Benzodiazepine sensitivity 
High benzodiazepine affinity (nM BZ affinity) 
BZ1 pharmacology (high zolpidem affinity) 
BZ2a,b pharmacology (low zolpidem affinity) 
BZ2c pharmacology (zolpidem insensitive) 
BZ3 pharmacology (BZR agonist insensitive) 
High zinc sensitivity 
Low zinc sensitivity (lC50 > 100 pM) 
Moderate zinc sensitivity (I& 10-100 pM) 
Enhancement by loreclezole 
High furosemide sensitivity (IC5,, < 10 pM) 
Moderate furosemide sensitivity (IC& 100 pM-l mM) 
Low furosemide sensitivity (I'& > 1 mM) 
< 10 pM) 
a and p with y2 
a l ,  1x2, a3, or a5 with y2, p 
a 1  with y2, p 
a2, a3 with y2, p 
a5 with y2, p 
a4 or a6 with y2, p 
a and p without y2 
a 1  and p with y2 
a4 or a6, p. y2,S or E and any a, p 
p2 or p3 present 
126 and p2 or p3 present 
a4 and p2 or p3 present 
a1, ~12,133, or a5 or pl present 
properties because they express specific GABA, recep- 
tor-subtype mRNAs at high levels. In situ hybridization 
studies have demonstrated that dentate granule cells pri- 
marily express mRNAs for a1,2,4, p1,3, y1,2, and 61 
GABA, receptor-subunit subtypes. Which subtypes as- 
semble to form native granule cell GABA, receptors is 
unknown. The a4-, pl- ,  yl- ,  and 61-subtype mRNAs 
have a restricted distribution in the brain, and each sub- 
type confers distinct pharmacologic properties. Although 
immunoprecipitation studies have not been performed on 
isolated preparations of dentate gyrus, a whole-brain im- 
munopurification study using a 6-specific antibody has 
been reported, demonstrating that the &subunit is asso- 
ciated with the a l - ,  a3-, p2/3-, and y2 subtypes. This 
study provided no information regarding expression of 
a3-, a4-, PI-, or yl-subtypes by granule cells. Immuno- 
precipitation studies did not reveal if subtype combina- 
tions precipitated from brains were functionally ex- 
pressed by granule cells. Finally, these studies did not 
determine if more than one GABA, receptor isoform 
was expressed by single granule cell (22). 
Pharmacology of dentate granule cell 
GABA, receptors 
The pharmacologic properties of GABA, receptor 
currents recorded from acutely dissociated hippocampal 
dentate granule cells from 28- to 35-day-old rats were 
characterized using the whole-cell patch-clamp tech- 
nique (23). Granule cells were voltage-clamped to 0 mV 
and GABA was applied using a modified U-tube rapid 
application technique. 
Concentration-dependent GABA, receptor currents 
were obtained from individual granule cells (Fig. 1A). 
Mean GABA EC,, was 46 & 10 pM, maximal current 
was 842 f 54 CpA, and the Hill slope was 1.2 (Fig. 1C). 
Diazepam-enhanced granule cell GABAA receptor cur- 
rents were evoked by 10 p,M GABA in a concentration- 
dependent fashion (Fig. 2A,B). Mean EC,, was 158 & 13 
nM, maximal enhancement was 210 & lo%, and the Hill 
slope was 1.2 & 0.3 (Fig. 2C). Zn++ reduced granule cell 
GABA, receptor currents evoked by 30 pM GABA in a 
concentration-dependent fashion (Fig. 3A,B). Mean IC,, 
was 28.5 f 11 pM, maximal inhibition was 77 ? 3%, and 
the Hill slope was 2.0 2 0.4 (Fig. 3C). 
INVOLVEMENT OF HIPPOCAMPAL GABA, 
RECEPTORS IN DEVELOPMENT OF 
STATUS EPILEPTICUS 
Hippocampal involvement in status epilepticus 
Several lines of evidence suggest that the hippocam- 
pal-parahippocampal loop can sustain seizures during 
status epilepticus. In functional mapping studies combin- 
ing EEG and 2-deoxyglucose mapping of metabolic ac- 
tivity during status epilepticus, increased glucose utili- 
zation occurred in hippocampal-parahippocampal struc- 
tures (subiculum, parasubiculum, and entorhinal cortex), 
limbic structures, including the amygdala, and extralim- 
bic structures (24). Similarly, GABA, receptor- 
combined hippocampal-parahippocampal slices sustain 
status epilepticus. Therefore, it is important to under- 
stand the functional properties of hippocampal GABAA 
receptors and how they are modified by status epilepti- 
Whole-animal studies of acute changes in the 
pharmacology of status epilepticus 
Status epilepticus was induced in Sprague-Dawley 
rats by intraperitoneal injection of 3 mEqkg LiCl, fol- 
lowed 20 h later by 50 mgkg pilocarpine (25). After 
pilocarpine injection, the rats were observed continu- 
ously for occurrence of behavioral seizures. The time to 
onset of behavioral seizures was recorded and the sei- 
zures were observed. Behavioral seizures evoked by 
lithiudpilocarpine were characterized by immobility, 
repetitive chewing, head nodding, vibrissial twitching, 
forelimb clonus with or without rearing, and falling 
(26,27). Seizure termination was defined as the absence 
of forelimb clonus or falling, facial twitching, and stop 
and stare activity. In addition, resumption of normal be- 
havior within 30 min of drug injection was assessed. 
Diazepam was administered 10 or 45 min after pilocar- 
pine injection. The proportion of rats that ceased to have 
cus. 
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FIG. 1. GABA concentration-response curve for a dentate granule cell isolated from a 30-day-old rat. A: Traces were from a single 
neuron and show responses to six concentrations of GABA. The concentration of GABA eliciting the current appears below the trace, and 
the bar indicates the duration of GABA application. B: The on rate of GABAR current is plotted as a function of GABA concentration. C: 
Pooled data from six neurons: each point represents the mean of five observations, and error bars show SEMs. The line was the best 
fit of the data to a sigmoidal function. The EC5, was derived from the equation for the sigmoid function that best fit the data. From Kapur 
et al. (23). 
seizures within 5 rnin of diazepam injection was plotted 
against log diazepam dose. The data were fitted to a 
sigmoidal dose-response curve, with the maximum fixed 
to 100% and minimum to 0%. The ED,,s were derived 
from the equation that best fitted the data. 
Behavioral seizures began 3-5 min after injection with 
pilocarpine. A detailed diazepam dose-response analysis 
was performed using a total of 30 rats. After 10 rnin of 
seizures, increasing doses of diazepam from 2 mgkg to 
20 mgkg were administered to four groups of rats: 2 
mgkg, n = 5; 7.5 mgkg, n = 3 ;  10 mgkg, n = 3; and 
20 mgkg, n = 3. After 45 min of seizures, three rats 
were treated with 20 mgkg, 30 mgkg, 50 mgkg, and 
100 mgkg of diazepam. Four rats were not treated with 
an AED and these rats continued to have seizures for 2 h. 
After 10 min of seizures, diazepam (20 mgkg) termi- 
nated seizures in all treated animals (n  = 3). However, 
after 45 rnin of seizures (status epilepticus), diazepam 
(20 mgkg) terminated the seizures in none of the ani- 
mals (n  = 3). At high doses of diazepam (50 mgkg and 
100 mgkg), behavioral seizures appeared terminated, 
but rats were extremely sedated and resumption of nor- 
mal activity did not occur. The dose-response data were 
fitted to a sigmoidal dose-response curve and the ED,,s 
for diazepam control of behavioral seizures after 10 min 
and 45 min of seizures were derived (Fig. 4). The dose- 
response curve showed that the ED,, for diazepam- 
induced termination of seizures shifted from 4.2 mgkg 
when administered after 10 min of continuous seizures to 
40 mgkg when administered after 45 min of continuous 
seizures. 
Because diazepam exerts its anticonvulsant effect pri- 
marily by enhancing GABAergic inhibition by acting on 
GABA, receptors (28), we hypothesized that seizures 
altered the functional properties of GABA, receptors. 
The seizures could potentially alter the modulation of 
GABA, receptor by various drugs, such as enhancement 
by benzodiazepines, barbiturates, and neurosteroids and 
antagonism by penicillin, picrotoxin, bicuculline, and 
Zn++. We characterized GABAA receptor currents re- 
corded from acutely isolated hippocampal dentate gran- 
ule cells, their potentiation by benzodiazepines and bar- 
biturates, and their inhibition by Zn++. 
Regulation of dentate granule cell GABA, receptor 
currents from rats undergoing status epilepticus 
GABA, receptor currents were reduced in granule 
cells from rats undergoing status epilepticus 
Whole-cell voltage-clamp recordings were made from 
dentate granule cells (29,30) acutely isolated from con- 
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FIG. 2. Diazepam-enhanced dentate granule cell GABAA receptor currents. A: The traces were from a single neuron. Concentrations of 
diazepam (DZP) applied with 10 pM GABA are shown below the traces. Horizontal bars show the duration of application of the drug. 
Recovery between drug application is not shown. B: Diazepam concentration-response curves for enhancement of GABA currents are 
plotted for seven cells. C: Each point represents the mean of seven observations, and the error bars show SEMs. The lines are the best 
fit of the data to a sigmoidal function. The EC, was derived from the equation for the sigmoid function that best fit the data. From Kapur 
et al. (23). 
trol rats or from same-age rats that experienced 45 min of 
continuous seizures (status epilepticus) (1). When access 
was initially established in granule cells from control 
rats, 10 FM GABA, receptor currents increased slightly 
and became stable in 2-4 min (run-up) (Fig. 5A). The 
stable response compared with the first response in- 
creased by 174 ? 47% (n = 4). In contrast, GABA, 
receptor currents evoked from granule cells from animals 
02.0 -is i . 0  -is 4.0 i . 5  - t o  
Log Zn++ [MI Log a++ [hq
FIG. 3. Zn++ inhibited dentate granule cell GABA, receptor currents. A: The traces were from a single neuron. Drug concentrations 
applied with 30 pM GABA are shown below the trace. Horizontal bars show the duration of drug application. Recovery between drug 
applications is not shown. Note the Zn++ inhibition of GABA, receptor currents was incomplete. 8: Zn++ concentration-response curves 
for inhibition of GABAR currents are plotted for eight cells. C: Each point represents the mean of the data from eight neurons, and the 
error bars show SEMs. The lines are the best fit of the data to a sigmoidal function. The IC, was derived from the equation for the sigmoid 
function that fit the data. From Kapur et al. (23). 
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FIG. 4. Diazepam was effective in controlling brief (lo-min) sei- 
zures but lost efficacy after prolonged (45 min) seizures. Seizures 
were induced in 70-150-g rats by i.p. injection of 3 mEq/kg LiCI, 
followed 16-24 h later by 50 mg/kg i.p. injection of pilocarpine. 
Behavioral seizures started within 1-5 rnin in all rats. Diazepam 
was administered 10 rnin (filledboxes, so/id/ine;n= 14) or 45 min 
(fifted circ/es, dashed line; n = 12) after pilocarpine injection. The 
proportion of rats that stopped having seizures within 5 min of 
diazepam injection was plotted against log diazepam dose. The 
data were fitted to a sigmoidal dose-response curve with the 
maximum fixed to 100% and minimum to 0%. The ED& were 
derived from the equation that best fit the data. From Kapur et al. (1). 
undergoing status epilepticus required 10 min to stabi- 
lize, and the run-up was substantially larger (374 2 66%; 
n = 5, p < 0.05; Fig. 5B). Once stable responses to 10 
pM GABA were obtained, GABA was applied to gran- 
ule cells at concentrations ranging from 1 to 1,000 pM 
(Fig. 6). For each of the groups, data from individual 
cells were pooled and fitted to a sigmoidal logistic equa- 
tion. In neurons from control animals, the mean GABA 
EC,, for GABAA receptors was 42 & 19 pM (n = 17), 
similar to that of neurons from animals undergoing status 
epilepticus: 33 & 14 pM; n = 9; (p > 0.05). The maximal 
GABA, receptor current in cells from control animals 
was 962 k 109 pA (n  = 19), similar to that of cells from 
animals undergoing status epilepticus: 820 k 188 pA ( n  
= 9). Thus, after status epilepticus there was increased 
run-up of GABA, receptor currents after initial access, 
but once stable currents had been obtained, the potency 
and efficacy of GABA on dentate granule cell GABA, 
receptors were similar to those in neurons from control 
animals. Modulation of GABA, receptor currents was 
studied in dentate granule cells isolated from control rats 
or from those undergoing status epilepticus after stabili- 
zation of currents. 
Diazepam enhancement of GABA, receptor currents 
was diminished in granule cells from rats undergoing 
status epilepticus 
In hippocampal dentate granule cells from control ani- 
mals, 10 pM GABA administered with 300 nM diaze- 
pam enhanced GABA, receptor currents in all neurons 
by 68 k 10% (n  = 6) (Fig. 7A). In contrast, in dentate 
granule cells from animals undergoing status epilepticus, 
300 nM diazepam inconsistently enhanced 6 or 10 pM 
GABA-evoked GABA, receptor currents by 10 & 6%; (n 
= 5; p < 0.001, grouped t test) (Fig. 7B). In neurons 
from control animals, 1 pM diazepam enhanced GABA, 
receptor currents by 92 f 6% (n  = 6), but in neurons 
from animals undergoing status epilepticus, 3 pM diaz- 
epam enhanced GABA, receptor currents by 5 1 f 8% (n  
= 5 ;  p < 0.05, grouped t test) (Fig. 7). The EC,, for 
diazepam enhancement of GABA, receptor currents in 
neurons from control animals was 195 & 12 nM, and the 
EC,, in neurons from animals undergoing status epilep- 
ticus was 4.4 & 0.25 pM (Fig. 8). Therefore, the pro- 
longed seizures of status epilepticus reduced the potency 
and efficacy of diazepam for enhancement of granule 
cell GABA, receptor currents. 
Zinc inhibition of GABA, receptor currents was 
diminished in granule cells from rats undergoing 
status epilepticus 
Because Zn++ modulation of recombinant GABAA re- 
ceptor currents varies inversely with benzodiazepine sen- 
sitivity (32,33), Zn++ inhibition of granule cell GABA, 
receptor currents was studied. Zn++ was less potent in 
inhibiting GABA, receptor currents recorded from gran- 
ule cells isolated from animals undergoing status epilep- 
ticus than from control granule cells. In neurons from 
control animals, GABA, receptor currents were inhib- 
ited 59 & 4% ( n  = 8) by 100 pM Zn++ (Fig. 9A), but in 
neurons isolated from animals undergoing status epilep- 
ticus the inhibition was reduced to 39 5 6% (n  = 6; p < 
0.05, grouped t test) (Fig. 9B). In dentate granule cells 
from control rats, GABA, receptor currents were re- 
duced by Zn++ in a concentration-dependent fashion with 
an IC,, of 30 & 3.6 pM (n  = 12) (Fig. 10). In dentate 
granule cells isolated from animals undergoing status 
epilepticus, the IC,, of Zn++ inhibition of GABA, re- 
ceptor currents was 123 f 15 pM ( n  = 10, p < 0.01, 
grouped t test) (Fig. 10). The maximal inhibition of 
GABA, receptor currents by Zn++ was unchanged (78 f 
3% in neurons from control animals and 90 & 16% in 
neurons from animals undergoing status epilepticus). 
Therefore, the prolonged seizures of status epilepticus 
reduced the potency of Zn++ without altering the efficacy 
of inhibition of granule cell GABA, receptor currents. 
Pentobarbital enhancement of GABA, receptor 
currents was unchanged in cells from rats undergoing 
status epilepticus 
In neurons from control animals ( n  = 6), GABA, 
receptor currents elicited by 10 pM GABA were en- 
hanced 77 & 7% by 30 pM pentobarbital (Fig. llA), 
whereas in neurons from animals undergoing status epi- 
lepticus (n  = 3), GABAA receptor currents elicited by 
10 pM GABA were enhanced 62 & 11% by 30 p,M 
pentobarbital ( P  > 0.05, grouped t test) (Fig. 11B). In 
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FIG. 5. Stabilization of GABA, receptor currents from dentate granule cells elicited immediately on access. Traces were from two 
neurons: (top) from a cell isolated from a control animal, and (bottom) from an animal undergoing status epilepticus. The durations of 
GABA application are indicated by bars. Two min elapsed between each GABA application. A: GABA, receptor currents elicited from 
hippocampal dentate granule cells isolated from control animals rapidly increased to a relatively stable amplitude. B: GABA, receptor 
currents elicited from hippocampal dentate granule cells isolated from animals undergoing status epilepticus took longer to stabilize and 
showed a greater increase in amplitude. From Kapur et al. (1). 
dentate granule cells from control animals (n  = 6), the 
pentobarbital EC,, was 42 & 15 FM, and in neurons from 
animals undergoing status epilepticus (n = 6) the pen- 
tobarbital EC,, was not significantly different: 36 2 8 
FM (Fig. 12). Maximal enhancement of GABA, recep- 
tor currents by pentobarbital in neurons from control rats 
(190 e 55%) and in neurons from animals undergoing 
status epilepticus (158 20%) were not significantly 
different (p > 0.05, grouped t test). Therefore, the pro- 
I c Naive 
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FIG. 6. GABA concentration dependency. GABA concentration- 
normalized GABA, receptor peak current relationships were plot- 
ted for 17 neurons isolated from control animals and nine neu- 
rons isolated from animals undergoing status epilepticus. Con- 
centration-response data were obtained after stabilization of 
currents. Each point represents the mean of normalized peak 
currents; error bars show SEMs. The line is the best fit of data to 
a sigmoidal function. The EC, and lmax were derived from the 
equation for the sigmoidal function that best fit the data. From 
Kapur et al. (1). 
longed seizures of status epilepticus did not alter the 
efficacy or potency of pentobarbital enhancement of 
GABA, receptor currents in dentate granule cells. 
DISCUSSION 
Diazepam loses effectiveness in the treatment of 
status epilepticus 
This study demonstrates the prolonged seizures of sta- 
tus epilepticus reduce the ability of diazepam to termi- 
nate status epilepticus. The refractoriness to diazepam 
results from loss of the potency but not the efficacy of 
diazepam. Refractoriness to diazepam has been previ- 
ously reported in both humans (34) and rats (27). Several 
possible mechanisms can be hypothesized to explain the 
loss of diazepam effectiveness in the treatment of the 
prolonged seizures of status epilepticus: seizures may 
become more intense; there may be enhanced excitatory 
transmission; or there may be altered inhibition. Past 
studies indicate the hippocampus is involved in the gen- 
eration of status epilepticus (2,35,36) and that hippocam- 
pal GABAergic inhibition is altered during status epilep- 
ticus (3,37,38). These studies suggest that refractoriness 
of seizures to diazepam might result from altered 
GABA, receptor function in the hippocampus. The ex- 
periments reported here support this hypothesis. 
Plasticity of GABA, receptor function during 
status epilepticus 
During status epilepticus, GABA, receptor-mediated 
inhibition in the hippocampus is reduced in both the CA 1 
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FIG.7. Diazepam enhancement of GABA, receptor currents 
from dentate granule cells of control animals and from cells iso- 
lated from rats after 45 min of seizures. Three hundred nanomo- 
lar diazepam-enhanced GABA, receptor currents in dentate 
granule cells from control animals but not those from cells iso- 
lated from rats after 45 min of seizures. The traces are from two 
different neurons. Horizontal bars show the duration of applica- 
tion of the drug. A: Three hundred nanomolar diazepam was 
applied with 10 pM GABA to a dentate granule cell from a control 
animal. B: 300 nM diazepam was applied with 6 pM GABA to a 
granule cell isolated from a rat after status epilepticus. A lower 
concentration of GABA was used to compensate for a small left 
shift of GABA concentration-response curve in cells from ani- 
mals undergoing status epilepticus (equipotent GABA concentra- 
tion). From Kapur et al. (1). 
+ 300 nM Diazepam 
region and the dentate gyms (3,38,39). One proposed 
mechanism for the reduction in inhibition is a specific 
alteration in the functional properties of GABA, recep- 
tors (38). We have demonstrated that two functional 
properties of GABA, receptors, diazepam enhancement 
and Znf+ inhibition of GABA, receptor currents, were 
altered by the prolonged seizures (1). This plasticity 
of GABA, receptors in the hippocampus may play a 
role in the pathogenesis and treatment of status epilepti- 
cus. Seizures in the hippocampus reduce GABAergic 
inhibition, and the findings presented here demon- 
strate that this is due in part to changes in GABA, re- 
ceptor function. The reduction in diazepam sensitivity 
of dentate granule cell GABA, receptors parallels the 
loss of effectiveness of diazepam in the treatment of 
experimental status epilepticus. It is possible that 
changes in the diazepam sensitivity of dentate granule 
cell GABA, receptors reflect reduction of diazepam 
sensitivity in the treatment of status epilepticus. In addi- 
tion, pentobarbital sensitivity of GABA, receptors on 
dentate granule cells isolated from animals undergoing 
status epilepticus was preserved. This suggested that sta- 
tus epilepticus alters specific properties of GABA, re- 
ceptors rather than causing a generalized dysfunction 
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FIG. 8. Diazepam concentration-dentate granule cell GABA, re- 
ceptor current enhancement relationships. Diazepam concentra- 
tion-response curves were obtained for neurons isolated from 
control animals (filled boxes, solid line; n = 9)  and for neurons 
isolated from animals undergoing status epilepticus (filled circles, 
dashedline; n = 12). Higher concentrations of diazepam inhibited 
GABA, receptor current as previously reported (31) nH, Hill 
slope. From Kapur et al. (1). 
Status epilepticus and temporal lobe epilepsy origin 
have distinct effects on hippocampal 
GABA, receptors 
Studies investigating the role of GABA, receptor- 
mediated inhibition in the hippocampus in kindling and 
other models of temporal lobe epilepsy are the most 
30 pM GABA +lo0 PM Zn++ 
Status Epirepticus h , [ 5 0 p A L  
30 pM GABA +I00 PM a++ 
FIG. 9. Zn++ inhibition of GABA, receptor currents in dentate 
granule cells from control animals and from animals undergoing 
status epilepticus. One hundred micromolar Zn++ inhibited 
GABA, receptor currents in dentate granule cells from control 
animals more than in granule cells from animals undergoing sta- 
tus epilepticus. The traces are from two different neurons. One 
hundred pM Zn++ was co-applied with 30 pM GABA. Horizontal 
bars show the duration of application of the drug. A: Traces from 
a dentate granule cell isolated from a control animal. B: Traces 
from a granule cell isolated from an animal undergoing status 
epilepticus. From Kapur et al. (1). 
Epilepsia, Vol. 40, Suppl. I ,  1999 








6 - 40- 
e 
t l  
C s 20- 
- -6 -5 -4 -3 
Log h++ [MI 
FIG. 10. Zn++ concentration-dentate granule cell GABA, recep- 
tor current reduction relationships. Zn++ concentration-dentate 
granule cell GABA, receptor current inhibition relationships were 
obtained from neurons isolated from control animals (filiedboxes, 
solidline; n = 12) and from neurons isolated from animals under- 
going status epilepticus (filled circles, dashed line; n = 12). The 
lines are the best fit of the data to a sigmoidal function. The IC, 
and Hill slope (nH) were derived from the equation for the sig- 
moidal function that best fit the data. From Kapur et al. (1). 
comparable to the current study. However, brief seizures 
of temporal lobe epilepsy and prolonged seizures of sta- 
tus epilepticus are distinct phenomena. Almost 50% of 
patients who experience an episode of status epilepticus 
have not previously had a seizure (40). Epileptic seizures 
are brief, and data from epilepsy monitoring units indi- 
cate that the majority of seizures spontaneously termi- 
nate within 10 min (41). In contrast, status epilepticus is 
a syndrome consisting of a very prolonged seizure with 
continuous evolution of neurologic state, worsening ce- 
rebral metabolism, a steady rise in core temperature, a 
rise in blood pressure, lactic acidosis, hyperglycemia 
(42), and increased catecholamine levels (43). Hippo- 
campal injury and neuronal loss occur as a result of status 
epilepticus in humans (44,45) and in most animal models 
of status epilepticus (46-50). However, whether indi- 
vidual brief seizures cause neuronal loss remains contro- 
versial (483 132). It is therefore expected status epilep- 
ticus and chronic temporal lobe epilepsy have different 
effects on hippocampal dentate granule cell GABA, re- 
ceptors. 
In kindling, subconvulsive electrical stimulation ap- 
plied repeatedly to various regions of the brain evokes 
progressively prolonged behavioral and EEG seizures 
that terminate in generalized tonic-clonic seizures. How- 
ever, there are important differences between the gradual 
plasticity occurring during the kindling process and the 
rapidly evolving changes of status epilepticus reported 
here. Several studies have reported enhanced [3H]- 
muscimol and [3H]-benzodiazepine binding in hippo- 
campal membranes (53) and specifically in the hippo- 
campal dentate gyrus (5435). This increase in the hip- 
pocampal dentate granule cell GABAA receptors after 
kindling was associated with an increase in the amplitude 
of miniature inhibitory postsynaptic currents and en- 
hancement of paired pulse depression of the kindled den- 
tate gyrus (56). These long-term changes in GABA, re- 
ceptor-mediated inhibition in the dentate gyrus were 
likely to be antiepileptic in nature. The findings of this 
study, however, do not contradict studies on the kindling 
model. Although inhibitory neurotransmission in the 
dentate gyrus was enhanced during kindling and dimin- 
ished during status epilepticus, the changes in kindling 
were slower to develop compared with the rapid changes 
that occur during status epilepticus. 
In electrical stimulation models of epilepsy, GAB A, 
receptor-mediated inhibition in the dentate gyrus was 
chronically reduced, but this reduction was hypothesized 
to be due to circuit rearrangement and dormancy of bas- 
ket cells (39). Recently, Buhl et al. (57) demonstrated 
enhanced Zn++ sensitivity of hippocampal dentate gran- 
ule cell GABA, receptors after kindling and suggested 
that this increased sensitivity resulted in a collapse of the 
augmented inhibition during seizures. Gibbs et al. (58) 
found increased GABA, receptor density and enhanced 
GABA, receptor Zn++ sensitivity in another model of 
chronic temporal lobe epilepsy. Several important dis- 
tinctions between these studies and this report pertain. 
First, the reduced diazepam sensitivity demonstrated 
here has not been reported in the past. Second, the 
A Naive 
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FIG. 11. Pentobarbital enhancement of GABA, receptor cur- 
rents from dentate granule cells from control animals and from 
cells isolated from animals undergoing status epilepticus. Thirty 
micromolar pentobarbital equally enhanced GABA, receptor cur- 
rents in dentate granule cells from control animals and granule 
cells from animals undergoing status epilepticus. The traces are 
from two different neurons. Thirty pM pentobarbital was co- 
applied with 10 pM GABA. Horizontal bars show the duration of 
application of the drug. A: Traces from a dentate granule cell 
isolated from a control animal. B: Traces from a granule cell 
isolated from an animal undergoing status epilepticus. From 
Kapur et al. (1). 
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FIG. 12. Pentobarbital concentration-dentate granule cell 
GABAA receptor current enhancement relationships. Pentobarbi- 
tat concentration-dentate granule cell GABAA receptor current 
enhancement relationships were obtained for neurons isolated 
from control animals (filled boxes, solid line; n = 7) and from 
neurons isolated from animals undergoing status epilepticus 
(filledcircles, dashedline; n = 6). The lines were the best fit of the 
data to a sigmoidal function. The EC,, and Hill slope (n,) were 
derived from the equation for the sigmoidal function that best fit 
the data. From Kapur et at. (1). 
changes that were observed in these studies were acute, 
occurring over minutes, whereas previous reports docu- 
mented changes that were chronic, occurring over sev- 
eral weeks. Finally, previous studies reported increased 
Zn++ sensitivity of hippocampal dentate granule cell 
GABA, receptors, whereas the current study reports di- 
minished Zn+* sensitivity of granule cell GABA, recep- 
tors. 
Possible molecular mechanisms for altered GABA, 
receptor function 
This rapid, selective loss of benzodiazepine and Zn++ 
sensitivity is a novel form of GABA, receptor plasticity, 
and the underlying molecular basis is unclear. Dimin- 
ished benzodiazepine sensitivity with development of 
benzodiazepine tolerance occurred over a prolonged pe- 
riod of time (59). During development of cerebellar gran- 
ule cells, benzodiazepine sensitivity of GABA, recep- 
tors is lost during maturation, in parallel with increasing 
expression of the a6-subtype in the GABA, receptor. 
Similarly, development of tolerance to benzodiazepines 
requires chronic benzodiazepine administration. 
This selective loss of benzodiazepine and Zn++ sensi- 
tivity may result from altered structural composition or 
altered state of phosphorylation of GABAA receptors. 
Diazepam sensitivity of GABAA receptors requires the 
presence of the y2-subtype with a P-subtype and either 
a l - ,  012-, a3-, or a5-subtype (13,60). Recombinant 
GABA, receptors expressed without the 72-subtype are 
highly sensitive to Znif (IC5,, < 10 kM, whereas 
GABA, receptors expressed with the y2-subtype were 
relatively insensitive to Zn++ (32,33). Therefore, one ex- 
planation for acute reduction of diazepam sensitivity of 
hippocampal dentate granule cell GAB A, receptors after 
seizures would be a loss of the y2-subtype from the 
receptor. However, this would not explain the dimin- 
ished Zn++ sensitivity of these receptors. Another poten- 
tial explanation for diminished diazepam and Zn++ sen- 
sitivity would be altered a-subtype expression, because 
a-subtypes are known to alter both Zn++ and diazepam 
sensitivity of the GABA, receptors. For example, re- 
combinant GABA, receptors with 014- or 1x6-subtype 
with a P-subtype and a y2-subtype have low diazepam 
and Zn++ sensitivities (61). 
Seizures may alter GABA, receptor function by other 
mechanisms, such as posttranslational modification of 
GABA, receptors or release of endogenous benzodiaz- 
epine-like substances. Modification of GABA, receptors 
by phosphorylation is well demonstrated (60,62,63), and 
seizures are known to modulate activities of CAMP- 
dependent protein kinase, calcium-calmodulin- 
dependent protein kinase, and calcium-phospholipid- 
dependent protein kinase (64,65). However, it remains to 
be shown that posttranslational modification can alter 
benzodiazepine and Zn++ sensitivity of GABA, recep- 
tors. 
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